$614.78
6.74 (-1.08%)
Last updated: May 31, 2026 05:46
Fundamentals Overview
Regeneron Pharmaceuticals, Inc. is in the middle of its 52-week range with low valuation, trading relatively flat today.
Valuation low
Intrinsic value (DCF)
+264.8% upside vs price
Profitability
Risk (Beta)
0.3 — lower vol
Earnings & growth
BullzEye Analysis
Our composite tilts Hold on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.
Composite Signal
Supporting (Buy):
DCF +264.8% upside vs price · Analyst grade: A
Pressures (Sell):
Sentiment weakening (2 downgrades) · 3M vs S&P 500: -30.7% · 3M vs Healthcare sector: -16.3%
Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.
Key Stats
About
Ratings & Grades at a Glance
Overall rating: A. Recent institutional grades: majority downgrades. Current institutional positions: Buy: 10, Equal Weight: 5, Market Perform: 1, Neutral: 1, Outperform: 4, Overweight: 6, Sector Perform: 3.
Valuation & Ratios
Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.
DCF vs price: DCF estimate is $2,242.68; current price is $614.78. That’s a +264.8% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.
| Metric | Value |
|---|---|
| Valuation | |
| P/E (TTM) | 14.97 |
| DCF value (model) | $2,242.68 (264.8% upside) |
| PEG (TTM) | N/A |
| P/B (TTM) | 2.03 |
| P/S (TTM) | 4.25 |
| P/FCF (TTM) | 15.24 |
| Liquidity & enterprise | |
| Current Ratio (TTM) | 3.57 |
| Quick Ratio (TTM) | 2.96 |
| Cash Ratio (TTM) | 0.58 |
| Profitability | |
| ROE (TTM) | N/A |
| ROA (TTM) | N/A |
| Revenue growth (YoY) | N/A |
| Net margin (TTM) | 29.65% |
| Gross margin (TTM) | 84.55% |
| Operating margin (TTM) | 24.32% |
| Debt to equity (TTM) | N/A |
Latest News
News loads when you open this tab.
Price Target, Ratings & Grades
Analyst price targets, consensus, rating snapshot, and institutional grades for REGN.
Analyst Sentiment at a Glance
Stock Grades (Institutions)
| Institution | Action | Previous Grade | New Grade | Date |
|---|---|---|---|---|
| Canaccord Genuity | maintain | Buy | Buy | 2026-05-19 |
| BMO Capital | maintain | Outperform | Outperform | 2026-05-18 |
| JP Morgan | maintain | Overweight | Overweight | 2026-05-18 |
| RBC Capital | maintain | Sector Perform | Sector Perform | 2026-05-18 |
| Leerink Partners | downgrade | Outperform | Market Perform | 2026-05-18 |
| Wells Fargo | maintain | Equal Weight | Equal Weight | 2026-05-18 |
| Citigroup | downgrade | Buy | Neutral | 2026-05-18 |
| Piper Sandler | maintain | Overweight | Overweight | 2026-05-18 |
| Truist Securities | maintain | Buy | Buy | 2026-05-18 |
| Guggenheim | maintain | Buy | Buy | 2026-05-01 |
| Wells Fargo | maintain | Equal Weight | Equal Weight | 2026-04-30 |
| RBC Capital | maintain | Sector Perform | Sector Perform | 2026-04-30 |
| Barclays | maintain | Overweight | Overweight | 2026-04-30 |
| Truist Securities | maintain | Buy | Buy | 2026-04-30 |
| Cantor Fitzgerald | maintain | Overweight | Overweight | 2026-04-23 |
| TD Cowen | maintain | Buy | Buy | 2026-04-23 |
| Morgan Stanley | maintain | Equal Weight | Equal Weight | 2026-04-10 |
| Bernstein | maintain | Outperform | Outperform | 2026-04-08 |
| Truist Securities | maintain | Buy | Buy | 2026-03-31 |
| RBC Capital | maintain | Sector Perform | Sector Perform | 2026-03-02 |
| Guggenheim | maintain | Buy | Buy | 2026-02-09 |
| Wells Fargo | maintain | Equal Weight | Equal Weight | 2026-02-02 |
| Oppenheimer | maintain | Outperform | Outperform | 2026-02-02 |
| Truist Securities | maintain | Buy | Buy | 2026-02-02 |
| Morgan Stanley | maintain | Equal Weight | Equal Weight | 2026-02-02 |
| JP Morgan | maintain | Overweight | Overweight | 2026-02-02 |
| Cantor Fitzgerald | maintain | Overweight | Overweight | 2026-02-02 |
| Evercore ISI Group | maintain | Outperform | Outperform | 2026-01-22 |
| Truist Securities | maintain | Buy | Buy | 2026-01-08 |
| B of A Securities | upgrade | Underperform | Buy | 2026-01-07 |